European Archives - Page 579 of 1054 - European Medical Journal

Type 2 Inflammation in Atopic Dermatitis and Beyond: Shared Pathophysiology and Clinical Management

Prof Maurer explored the common role of type 2 inflammation in the shared pathophysiology and epidemiology of AD and other type 2 inflammatory diseases…

Cross-Sectional Study of Ethnicity and Chronic Heart Failure: Complex Interplay of Health and Wealth

Heart failure affects up to 26 million adults worldwide.1 The overall economic cost of heart failure in 2012 was estimated to be $108 billion per annum…

Patients with CV conditions & Covid-19: what have we learned from patients’ & doctors’ experiences?

Cardiovascular patients, Winfried Klausnitzer and Patricia Vlasman, join Neil Johnson, Director, Development & Strategy, Global Heart Hub and Professor Salvatore Di Somma, Professor of Medicine, Sapienza University of Rome, to share their respective experiences of facing the COVID-19 pandemic, in this webinar, facilitated by Professor Jonathan Sackier.

EMJ Podcast: What's Up Doc?

This week, Jonathan Sackier delves into the pertinent subject of physician mental health. Listen now to find out more

Distinct Immune Response Profiles Correlate With COVID-19 Disease Severity

DIFFERING immune system responses of patients with COVID-19 indicate which patients are at greater risk of developing severe forms of the illness…

Can Exposure to Common Cold Human Coronaviruses Lead to Immunological Memory in SARS-CoV-2?

MEMORY T cells that recognise common cold coronaviruses may teach the immune system to recognise matching sites on SARS-CoV-2, explaining why…

The BEST Conference

Launching a new medical device is anything but simple; it is a complex labyrinth. An inventor has an idea which must obtain intellectual property…

Nutritional Management of Paediatric Crohn’s Disease

For many people with Crohn’s disease (CD), onset occurs in childhood or adolescence. Treatment for CD has moved from predominantly surgical to…

EMJ Oncology 8 [Supplement 1] Feature Image

EMJ Oncology 8 [Supplement 1] 2020

Up to 80% of patients with cancer are affected by chemotherapy-induced nausea and vomiting (CINV) if the appropriate preventive healthcare…

EMJ Oncology 8 [Supplement 1] Feature Image

Initiatives to Improve Control, Resource Use, and Quality of Life Associated with Chemotherapy-Induced Nausea and Vomiting

This review set out to identify the initiatives needed to achieve better cancer-induced nausea and vomiting (CINV) control worldwide…